Researchers from Charité – Universitätsmedizin Berlin and the Zuse Institute Berlin have developed a new generation of pain medications.
The researchers used computer simulations to develop new opioids that will only work at sites affected by injury or inflammation. These drugs can prevent the occurrence of brain- and gut-related side effects typically associated with conventional opioids and have been shown to be successful in preclinical studies. Results from this research have been published in Pain* and Scientific Reports**.
Opioids are a class of drugs with powerful pain-relieving properties. They are mainly used to treat the pain associated with tissue damage and inflammation, such as that caused by surgery or cancer. Common side effects associated with their use include drowsiness, nausea, constipation, dependency and, in some cases, respiratory arrest. The research team, which is led by Prof. Dr. Christoph Stein of the Department of Anesthesiology and Surgical Intensive Care Medicine on Campus Benjamin Franklin, are hoping to develop new types of pain medications which will work without producing dangerous side effects. Collaborating with PD Dr. Marcus Weber of the Zuse Institute Berlin, the researchers used computer simulations to develop two new opioids. In both cases, the researchers used fentanyl as the starting molecule.
The researchers hypothesized that tissues which are damaged or inflamed show stronger interaction between ‘opioid agonists’ – the substances that elicit the pain-relieving effect – and the opioid receptors they bind to. Their computer simulations suggested that this is due to an increased concentration of protons in inflamed tissues, which leads to lower pH values than in healthy tissues, resulting in acidic conditions. Opioid molecules need to undergo protonation before they can bind to and activate opioid receptors. The researchers used this knowledge to design two drugs that would only exist in their protonated state in the presence of inflammation. This restricts opioid receptor activation to sites of tissue damage or inflammation, rather than receptors in the brain or gut.
“Our innovative design method provides a robust basis for a new generation of pain medications,” reports Prof. Stein. He adds: “These drugs could help us both to avoid the dangerous side effects of conventional opioids and to reduce complications. They would also help us stem the opioid crisis, a problem that is particularly evident in the United States.”
The researchers hope to further develop these newly-designed drugs in order to make them available to patients. They also plan to enhance their understanding of the molecular processes underlying the complex interactions seen in inflamed tissues, in the hope that they may be able to support opioid optimization through the insights they gain. Ideally, their insights will also be beneficial for other drugs, such as those used to treat high blood pressure.
The Latest on: Pain medications
via Google News
The Latest on: Pain medications
- WellsCare to target Middle Eastern market for its homecare laser pain treatment deviceon July 2, 2020 at 5:30 am
WellsCare, a member company of the Born2Global Centre, will be expanding its presence in the Middle East starting in July. WellsCare has ...
- Worldwide Impact of Covid-19 on OTC Pain Medications Market Revenue Strategy 2020: GlaxoSmithKline, Merck, Pfizer, Novartis, etc.on July 2, 2020 at 4:28 am
The OTC Pain Medications Market report covers a detailed competitive outlook that includes the market share and company profiles of key players operating in the global market. This report analyses the ...
- The pain management revolutionon July 2, 2020 at 4:10 am
To avoid the potential dangers of opioids, many doctors and patients are now turning to new medication and methods for pain management.
- Global Osteoarthritis Pain Drugs Market 2020 Key Dynamics, Recent and Future Demand, Trend, Analysis upto 2026on July 1, 2020 at 5:35 pm
The recently added market research study Global Osteoarthritis Pain Drugs Market 2020 by Manufacturers, Regions, Type and Application, Forecast to 2026 presents a detailed assessment of the market and ...
- Tips for Living Better With Joint Painon July 1, 2020 at 4:18 pm
Most commonly caused by arthritis or related diseases of the joints, this pain is estimated to affect more than 70 million patients in the U.S. and some 300 million people worldwide, says Dr. Taylor R ...
- Acupuncture and cupping known to relieve pain, stress and anxietyon July 1, 2020 at 1:40 pm
Acupuncture is the process of inserting very thin needles into your skin at specific parts of your body to help relieve pain. "Really what acupuncture is doing is helping with cir ...
- Living With Sickle Cell Disease Is a Constant Battle With Pain, According to One Woman Who Has Iton July 1, 2020 at 1:18 pm
Sickle cell disease, or sickle cell anemia, is a genetic blood disorder that causes chronic pain. Find out more about living with sickle cell from a woman who has had it her entire life.
- Doctors prescribing more muscle relaxants for back painon July 1, 2020 at 12:23 pm
Back pain plagues many Americans, and new research shows that doctors are doling out muscle relaxant prescriptions to treat the pain -- often along with an opioid painkiller.
- Pain relief drugs offer more choices for women during childbirthon June 30, 2020 at 11:04 pm
Choice and control are important factors for ensuring a positive childbirth experience, yet until recently, little was known about the impact of alternative administrations of fentanyl – one of the ...
via Bing News